Discontinuation report OMEPRAZOLE
Report ID | 47840 |
Drug Identification Number | 02385384 |
Brand name | OMEPRAZOLE |
Common or Proper name | OMEPRAZOLE |
Company Name | SIVEM PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | OMEPRAZOLE |
Strength(s) | 20MG |
Dosage form(s) | CAPSULE (DELAYED RELEASE) |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | A02BC |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2018-06-15 |
Actual discontinuation date | 2018-06-15 |
Remaining supply date | 2018-06-15 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2018-06-26 | French | Compare |
v5 | 2018-06-26 | English | Compare |
v4 | 2018-05-04 | French | Compare |
v3 | 2018-05-04 | English | Compare |
v2 | 2018-05-01 | French | Compare |
v1 | 2018-05-01 | English | Compare |
Showing 1 to 6 of 6